CoChat

Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development

Open access
Yoo, Stephen S, Jorgensen, Timothy J, Kennedy, Ann R, Boice Jr, John D, Shapiro, Alla, Hu, Tom C-C, Moyer, Brian R, Grace, Marcy B, Kelloff, Gary J, Fenech, Michael, Prasanna, Pataje G S, Coleman, C Norman · 2014 · Journal of Radiological Protection
Cited by 221

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The United States radiation medical countermeasures (MCM) programme for radiological and nuclear incidents has been focusing on developing mitigators for the acute radiation syndrome (ARS) and delayed effects of acute radiation exposure (DEARE), and biodosimetry technologies to provide radiation dose assessments for guiding treatment. Because a nuclear accident or terrorist incident could potentially expose a large number of people to low to moderate doses of ionising radiation, and thus increase their excess lifetime cancer risk, there is an interest in developing mitigators for this purpose. This article discusses the current status, issues, and challenges regarding development of mitigators against radiation-induced cancers. The challenges of developing mitigators for ARS include: the long latency between exposure and cancer manifestation, limitations of animal models, potential side effects of the mitigator itself, potential need for long-term use, the complexity of human trials to demonstrate effectiveness, and statistical power constraints for measuring health risks (and reduction of health risks after mitigation) following relatively low radiation doses (<0.75 Gy). Nevertheless, progress in the understanding of the molecular mechanisms resulting in radiation injury, along with parallel progress in dose assessment technologies, make this an opportune, if not critical, time to invest in research strategies that result in the development of agents to lower the risk of radiation-induced cancers for populations that survive a significant radiation exposure incident.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1088/0952-4746/34/2/r25

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 221

Metadata

Authors
Yoo, S. S., Jorgensen, T. J., Kennedy, A. R., Boice Jr, J. D., Shapiro, A., Hu, T. C.-C., Moyer, B. R., Grace, M. B., Kelloff, G. J., Fenech, M., Prasanna, P. G. S., & Coleman, C. N.
Venue
Journal of Radiological Protection
Published
2014-04-14
Volume
34
Issue
2
Pages
R25-R52
ISSN
  • 0952-4746 (ISSN-L)
  • 1361-6498
OpenAlex
W2010962051
Cited by
221
References
10
FWCI
33.67
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development. https://app.cochat.ai/papers/10.1088/0952-4746/34/2/r25
The paper
Yoo, S. S., Jorgensen, T. J., Kennedy, A. R., Boice Jr, J. D., Shapiro, A., Hu, T. C.-C., Moyer, B. R., Grace, M. B., Kelloff, G. J., Fenech, M., Prasanna, P. G. S., & Coleman, C. N. (2014). Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development. Journal of Radiological Protection. https://doi.org/10.1088/0952-4746/34/2/r25

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.